The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 208 results:
Author [ Title(Asc)] Type Year
Filters: Author is Tziomalos, Konstantinos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Koiou, E., Tziomalos K., Katsikis I., Kandaraki E. A., Kalaitzakis E., Delkos D., et al. (2012).  Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.. Gynecol Endocrinol. 28(1), 20-4.
V
Alkagiet, S., & Tziomalos K. (2017).  Vascular calcification: the role of microRNAs.. Biomol Concepts. 8(2), 119-123.
U
Panidis, D., Tziomalos K., Papadakis E., Vosnakis C., Betsas G., Tsourdi E., et al. (2014).  Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome.. Endocr Pract. 20(6), 540-7.
Sofogianni, A., Tziomalos K., Koletsa T., Pitoulias A. G., Skoura L., & Pitoulias G. A. (2020).  Using serum biomarkers for identifying unstable carotid plaque: update of current evidence.. Curr Pharm Des.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
Tziomalos, K., Krassas G. E., & Tzotzas T. (2009).  The use of sibutramine in the management of obesity and related disorders: an update.. Vasc Health Risk Manag. 5(1), 441-52.
Tziomalos, K. (2016).  Unresolved issues in lipid-lowering treatment.. Panminerva Med. 58(2), 191-5.
Karagiannis, A., Tziomalos K., Krikis N., Sfikas G., Dona K., & Zamboulis C. (2005).  The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment of hypertension.. Angiology. 56(5), 565-9.
T
Tziomalos, K., Spanou M., Bouziana S. D., Papadopoulou M., Giampatzis V., Kostaki S., et al. (2014).  Type 2 diabetes is associated with a worse functional outcome of ischemic stroke.. World J Diabetes. 5(6), 939-44.
Tziomalos, K., Athyros V. G., Karagiannis A., Kolovou G. D., & Mikhailidis D. P. (2009).  Triglycerides and vascular risk: insights from epidemiological data and interventional studies.. Curr Drug Targets. 10(4), 320-7.
Papagianni, M., Tziomalos K., Kostaki S., Angelopoulou S-M., Christou K., Bouziana S. D., et al. (2018).  Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema.. Am J Cardiovasc Drugs. 18(5), 397-403.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.. Cerebrovasc Dis. 41(5-6), 226-32.
Athyros, V. G., Tziomalos K., & Karagiannis A. (2015).  Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.. Expert Rev Cardiovasc Ther. 13(9), 1059-66.
Krikis, N., Tziomalos K., Perifanis V., Vakalopoulou S., Karagiannis A., Garypidou V., et al. (2004).  Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with administration of octreotide LAR and propranolol.. Hormones (Athens). 3(1), 65-7.
Tziomalos, K., Vakalopoulou S., Perifanis V., & Garipidou V. (2009).  Treatment of congenital fibrinogen deficiency: overview and recent findings.. Vasc Health Risk Manag. 5, 843-8.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  To switch (statins) or not to switch? That is the question.. Expert Opin Pharmacother. 11(18), 2943-6.
Athyros, V. G., Gossios T. D., Tziomalos K., Florentin M., Karagiannis A., & Mikhailidis D. P. (2011).  Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?. Arch Med Sci. 7(6), 1067-75.
Athyros, V. G., Mikhailidis D. P., Papageorgiou A. A., Didangelos T. P., Peletidou A., Kleta D., et al. (2005).  Targeting vascular risk in patients with metabolic syndrome but without diabetes.. Metabolism. 54(8), 1065-74.
S
Tziomalos, K., Dimitriou P., Bouziana S. D., Spanou M., Kostaki S., Angelopoulou S-M., et al. (2017).  Stress hyperglycemia and acute ischemic stroke in-hospital outcome.. Metabolism. 67, 99-105.
Athyros, V. G., Kakafika A. I., Tziomalos K., Papageorgiou A. A., & Karagiannis A. (2008).  Statins for the prevention of first or recurrent stroke.. Curr Vasc Pharmacol. 6(2), 124-33.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2009).  Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.. Curr Vasc Pharmacol. 7(3), 264-6.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Pagourelias E. D., Savvatianos S. D., Elisaf M., et al. (2007).  Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.. Open Cardiovasc Med J. 1, 8-14.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Statin-fibrate combination for mixed dyslipidaemia: a limited option?. Curr Med Res Opin. 26(9), 2137-40.
Athyros, V. G., Tziomalos K., Florentin M., Karagiannis A., & Mikhailidis D. P. (2010).  Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?. Curr Med Res Opin. 26(4), 839-42.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.